Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06464380 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma

StatusUnknown
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 23, 2024 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Start date: Jul 30, 2024 to Oct 30, 2024 Primary completion date: Mar 1, 2025 to May 1, 2025 · Completion date: Aug 1, 2025 to Oct 1, 2025v4 Show 2 more changesShow less
    • Primary completion date: Mar 1, 2025 to May 1, 2025
    • Completion date: Aug 1, 2025 to Oct 1, 2025
  3. Collaborators revised (5)v3 See this version in full on ClinicalTrials.gov ↗
  4. Interventions: Saffranal (Dietary Supplement) to Placebo (Dietary Supplement), Saffranal (Dietary Supplement)v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Saffron has recently gained considerable interest for its capacity to interfere with cancer at initiation and promotion stages as well as for cancer treatment. Although saffron and its constituents have been shown to have antitumorigenic and proapoptotic activities in different cancer cell lines. The aim of the current investigation is to identify the anti-cancer potentiality of saffron on hepatocellular carcinoma patients.
Trial Details
NCT Number NCT06464380
Lead Sponsor Ain Shams University
Collaborators: Mohamed, Ahmed A., M.D., Amr Amin College of Medicine, University of Sharjah, Sharjah 27272, UAE., Ahmed Cordie Endemic Medicine department, Cairo University Hospitals., Nouran Mohamed Endemic Medicine department, Cairo University Hospitals., Misr University for Science and Technology
Conditions Hepatocellular Carcinoma
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov